Rosenberg Receives Keio Medical Science Prize Steven A. Rosenberg, M.D., Ph.D., a pioneer in the fields of basic tumor immunology and cancer immunotherapy, can add recipient of the 17th annual Keio Medical Science Prize to his list of academic and professional honors. The prize, awarded by Keio University in Tokyo, recognizes the outstanding and creative achievements of researchers in the fields of medicine and life sciences, in particular those contributing to scientific developments in medicine. Six recipients of the Keio Medical Science Prize have later won the Nobel Prize. Rosenberg, chief of surgery at the National Cancer Institute and head of the Tumor Immunology Section in NCI’s Center for Cancer Research, has been at the forefront of efforts to develop an effective immunotherapy for human cancer. In his recent work, he has used genetic engineering to develop anti-tumor immune lymphocytes. “I am deeply grateful to the selection committee for awarding me the very prestigious Keio Medical Science Prize,” Rosenberg said. “This award recognizes our efforts to develop new immunotherapies for patients with cancer. It is a great honor to be able to work to develop new treatments for patients with this devastating disease.”

Steven A. Rosenberg, M.D., Ph.D.

Steven A. Rosenberg, M.D., Ph.D., a pioneer in the fields of basic tumor immunology and cancer immunotherapy, can add recipient of the 17th annual Keio Medical Science Prize to his list of academic and professional honors.

The prize, awarded by Keio University in Tokyo, recognizes the outstanding and creative achievements of researchers in the fields of medicine and life sciences, in particular those contributing to scientific developments in medicine. Six recipients of the Keio Medical Science Prize have later won the Nobel Prize.

Rosenberg, chief of surgery at the National Cancer Institute and head of the Tumor Immunology Section in NCI’s Center for Cancer Research, has been at the forefront of efforts to develop an effective immunotherapy for human cancer. In his recent work, he has used genetic engineering to develop anti-tumor immune lymphocytes.

“I am deeply grateful to the selection committee for awarding me the very prestigious Keio Medical Science Prize,” Rosenberg said. “This award recognizes our efforts to develop new immunotherapies for patients with cancer. It is a great honor to be able to work to develop new treatments for patients with this devastating disease.”